Literature DB >> 24516227

The association between left ventricular global longitudinal strain, renal impairment and all-cause mortality.

Rathika Krishnasamy1, Nicole M Isbel1, Carmel M Hawley1, Elaine M Pascoe2, Rodel Leano3, Brian A Haluska3, Tony Stanton3.   

Abstract

BACKGROUND: Left ventricular (LV) systolic dysfunction is an important predictor of cardiovascular death. Global longitudinal strain (GLS) is a widely available echocardiographic technique proven to be more sensitive than conventional ejection fraction (EF) in detecting subtle changes in LV function. However, the prognostic value of GLS in patients with chronic kidney disease (CKD) is unknown.
METHODS: We studied 447 patients from a single center who were stratified according to estimated glomerular filtration rate (eGFR). GLS was calculated using two-dimensional speckle tracking and EF was measured using Simpson's biplane. Cox proportional hazard model was used to identify independent predictors of survival and measures of discrimination and reclassification were used to assess the predictive value of GLS. Multivariable regression models were used to evaluate clinical and laboratory factors associated with GLS.
RESULTS: The mean EF was 58 ± 11% and GLS was -16.6 ± 4.2%. eGFR correlated negatively with GLS (r = -0.14, P = 0.004). Factors that were independently associated with GLS include gender, previous myocardial infarction, eGFR and phosphate (R(2) = 0.16, P < 0.001). Sixty-four patients died in a follow-up of 5.2 ± 1.4 years. GLS remained a significant predictor of all-cause mortality [hazard ratio (HR) 1.08, 95% confidence interval (CI) 1.01-1.15] following adjustment for age, diabetes mellitus, hypertension, eGFR and left ventricular mass index (LVMI). The strength of association between demographic data, eGFR, LVMI and mortality increased following addition of GLS [c-statistic 0.68 (95% CI 0.61-0.74) to 0.71 (95% CI 0.64-0.77), P = 0.04]. Addition of GLS also demonstrated a 21% net reclassification improvement in risk prediction for all-cause mortality over clinical factors.
CONCLUSIONS: GLS is an important predictor of all-cause mortality in CKD patients. Traditional and non-traditional risk factors such as phosphate are important determinants of GLS. Strain assessment in CKD patients may provide greater cardiovascular risk stratification.
© The Author 2014. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  all-cause mortality; chronic kidney disease; ejection fraction; global longitudinal strain

Mesh:

Year:  2014        PMID: 24516227     DOI: 10.1093/ndt/gfu004

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  19 in total

1.  Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort.

Authors:  Ruth F Dubin; Rajat Deo; Nisha Bansal; Amanda H Anderson; Peter Yang; Alan S Go; Martin Keane; Ray Townsend; Anna Porter; Matthew Budoff; Shaista Malik; Jiang He; Mahboob Rahman; Jackson Wright; Thomas Cappola; Radhakrishna Kallem; Jason Roy; Daohang Sha; Michael G Shlipak
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-10       Impact factor: 8.237

2.  Subclinical myocardial disease in patients with primary hyperoxaluria and preserved left ventricular ejection fraction: a two-dimensional speckle-tracking imaging study.

Authors:  Ruth Lagies; Floris E A Udink Ten Cate; Markus Feldkötter; Bodo B Beck; Narayanswami Sreeram; Bernd Hoppe; Ulrike Herberg
Journal:  Pediatr Nephrol       Date:  2019-08-22       Impact factor: 3.714

3.  Incremental value of global longitudinal strain in prediction of all-cause mortality in predialysis and dialysis chronic kidney disease patients.

Authors:  Ivana Valocikova; Marianna Vachalcova; Gabriel Valocik; Marian Kurecko; Mariana Dvoroznakova; Peter Mitro; Jozefina Cocherova; Stanislava Buday Bujnakova; Dusan Holoubek
Journal:  Wien Klin Wochenschr       Date:  2016-03-14       Impact factor: 1.704

4.  Longitudinal assessment of myocardial function in childhood chronic kidney disease, during dialysis, and following kidney transplantation.

Authors:  Rawan K Rumman; Ronand Ramroop; Rahul Chanchlani; Mikaeel Ghany; Diane Hebert; Elizabeth A Harvey; Rulan S Parekh; Luc Mertens; Michael Grattan
Journal:  Pediatr Nephrol       Date:  2017-03-08       Impact factor: 3.714

Review 5.  Echocardiographic assessment of cardiac structure and function in chronic renal disease.

Authors:  Kaoru Dohi
Journal:  J Echocardiogr       Date:  2019-07-08

Review 6.  Influence of chronic kidney disease on cardiac structure and function.

Authors:  Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

7.  Plasma biomarkers outperform echocardiographic measurements for cardiovascular risk prediction in kidney transplant recipients: results of the HOME ALONE study.

Authors:  Insa E Emrich; Anja L Scheuer; Kyrill S Rogacev; Felix Mahfoud; Stefan Wagenpfeil; Danilo Fliser; Stephan H Schirmer; Michael Böhm; Gunnar H Heine
Journal:  Clin Kidney J       Date:  2021-10-28

8.  Left ventricular mechanical dyssynchrony assessment in long-standing type II diabetes mellitus patients with normal gated SPECT-MPI.

Authors:  Dharmender Malik; Bhagwant Mittal; Ashwani Sood; Madan Parmar; Gurvinder Kaur; Ajay Bahl
Journal:  J Nucl Cardiol       Date:  2018-02-01       Impact factor: 5.952

9.  T Cells Play a Causal Role in Diastolic Dysfunction during Uremic Cardiomyopathy.

Authors:  Pamela D Winterberg; Jennifer M Robertson; Michael S Kelleman; Roshan P George; Mandy L Ford
Journal:  J Am Soc Nephrol       Date:  2019-02-06       Impact factor: 10.121

10.  Association of Global Longitudinal Strain With Clinical Status and Mortality in Patients With Chronic Heart Failure.

Authors:  Sven-Oliver Tröbs; Jürgen H Prochaska; Sören Schwuchow-Thonke; Andreas Schulz; Felix Müller; Marc William Heidorn; Sebastian Göbel; Simon Diestelmeier; Jaume Lerma Monteverde; Karl J Lackner; Tommaso Gori; Thomas Münzel; Philipp S Wild
Journal:  JAMA Cardiol       Date:  2021-04-01       Impact factor: 30.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.